Medicine & Life Sciences
Cost-Benefit Analysis
100%
Costs and Cost Analysis
55%
Randomized Controlled Trials
47%
Quality-Adjusted Life Years
37%
Systematic Reviews
33%
National Institutes of Health (U.S.)
32%
Embryo Transfer
29%
Health Care Costs
25%
Diabetic Retinopathy
24%
Retained Placenta
20%
Health Services
19%
Varicose Veins
19%
Endometrial Ablation Techniques
19%
Scotland
19%
Therapeutics
19%
Economics
18%
Delivery of Health Care
18%
Cognitive Behavioral Therapy
17%
Live Birth
17%
Fertilization in Vitro
17%
Menorrhagia
16%
Direct Service Costs
16%
Single Embryo Transfer
16%
Laser Therapy
16%
Chronic Renal Insufficiency
15%
Chronic Pain
15%
Sclerotherapy
15%
Telephone
15%
Macular Degeneration
15%
Nitroglycerin
14%
Confidence Intervals
14%
Quality of Life
13%
Exercise
13%
Reproduction
13%
Hysterectomy
12%
Acute Kidney Injury
12%
Hereditary Angioedemas
12%
Denosumab
12%
Embryonic Structures
12%
Odds Ratio
11%
Angle Closure Glaucoma
11%
Seasonal Allergic Rhinitis
10%
Asthma
10%
Nitric Oxide
10%
Osteoporotic Fractures
10%
Placebos
10%
Vitamin K
10%
Freezing
10%
Macular Edema
10%
Status Epilepticus
10%
Social Sciences
costs
32%
chronic illness
19%
economics
16%
evaluation
12%
life years
10%
health
9%
confidence
9%
management
9%
evidence
8%
non-intervention
7%
diagnostic study
6%
technology assessment
6%
coherence
6%
economic value
5%
diagnostic
5%
embryo
5%
stroke
5%